107 assets in Malignant Glioma

Therapeutic assets addressing Malignant Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lorlatinib Malignant Glioma	Nationwide Children's Hospital	Early P1	C (38)
Silevertinib Malignant Glioma	St. Joseph's Hospital and Medical Center, Phoenix	Early P1	C (38)
Temsirolimus Malignant Glioma	Nader Sanai	Early P1	C (38)
Neopep Vaccine1 Malignant Glioma	Shanghai 10th People's Hospital	N/A	D (30)
Neopep Vaccine2 Malignant Glioma	Shanghai 10th People's Hospital	N/A	D (30)
bc008-1a Malignant Glioma	Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.	P1	NR ()
Fz-Ad005 Malignant Glioma	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.	P1	NR ()

Showing 101 to 107 of 107 assets

PreviousPage 3 of 3Next